Stifel Financial’s Axsome Therapeutics AXSM Stock Holding History

Stifel Financial’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Buy	7,421 +1,501	+25%	+$326K	﹤0.01%	2162
2026 Q1	$1M	Buy	5,920 +52	+0.9%	+$8.98K	﹤0.01%	2460
2025 Q4	$1.07M	Buy	5,868 +361	+7%	+$50.4K	﹤0.01%	2399
2025 Q3	$669K	Buy	5,507 +1,185	+27%	+$133K	﹤0.01%	2637
2025 Q2	$451K	Buy	+4,322	New	+$458K	﹤0.01%	2836
2021 Q3	–	Sell	-406,935	Closed	-$27.5M	–	3334
2021 Q2	$27.5M	Buy	406,935 +136	+0%	+$8.16K	0.04%	363
2021 Q1	$23M	Buy	406,799 +769	+0.2%	+$54.1K	0.04%	391
2020 Q4	$33.1M	Sell	406,030 -538	-0.1%	-$40.2K	0.06%	285
2020 Q3	$29M	Sell	406,568 -30	-0%	-$2.34K	0.06%	280
2020 Q2	$33.5M	Buy	406,598 +2,453	+0.6%	+$189K	0.08%	238
2020 Q1	$23.8M	Hold	404,145	–	–	0.07%	256
2019 Q4	$41.8M	Hold	404,145	–	–	0.09%	225
2019 Q3	$8.18M	Sell	404,145 -374	-0.1%	-$9.61K	0.02%	637
2019 Q2	$10.4M	Buy	404,519 +374	+0.1%	+$7.5K	0.03%	558
2019 Q1	$5.75M	Hold	404,145	–	–	0.02%	754
2018 Q4	$1.14M	Hold	404,145	–	–	﹤0.01%	1449
2018 Q3	$1.39M	Hold	404,145	–	–	﹤0.01%	1466
2018 Q2	$1.29M	Hold	404,145	–	–	﹤0.01%	1456
2018 Q1	$990K	Sell	404,145 -11,134	-3%	-$33.3K	﹤0.01%	1568
2017 Q4	$2.33M	Hold	415,279	–	–	0.01%	1082
2017 Q3	$2.31M	Hold	415,279	–	–	0.01%	1046
2017 Q2	$2.28M	Hold	415,279	–	–	0.01%	1040
2017 Q1	$1.62M	Hold	415,279	–	–	0.01%	1178
2016 Q4	$2.8M	Hold	415,279	–	–	0.01%	893
2016 Q3	$3.27M	Buy	+415,279	New	+$3.14M	0.01%	796

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Stifel Financial's AXSM Position: Q2 2026 in Review

Stifel Financial increased its Axsome Therapeutics (AXSM) stake by 25% in Q2 2026, buying an estimated $326K and bringing the position to 7,421 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2162.

Stifel Financial first reported a position in AXSM in Q3 2016 and has held it in 25 quarters since. The position peaked at $41.8M in Q4 2019. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Stifel Financial held 7,421 shares of Axsome Therapeutics worth $1.82M as of Q2 2026.
Stifel Financial bought 1,501 Axsome Therapeutics shares in Q2 2026, an estimated $326K.
Axsome Therapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2162 holding.
Stifel Financial first reported a position in Axsome Therapeutics in Q3 2016 and has held it in 25 quarters since.
Stifel Financial's Axsome Therapeutics position peaked at $41.8M in Q4 2019.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.